These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Life support for life science innovation? Nat Biotechnol; 2007 Feb; 25(2):144. PubMed ID: 17287731 [TBL] [Abstract][Full Text] [Related]
7. Biotech's wellspring: the health of private biotech in 2012. Huggett B Nat Biotechnol; 2013 May; 31(5):396-403. PubMed ID: 23657390 [No Abstract] [Full Text] [Related]
8. Boutiques reborn in 2003. Surendran A Nat Biotechnol; 2004 Mar; 22(3):353-4. PubMed ID: 15017987 [No Abstract] [Full Text] [Related]
10. Biotech IPOs--flop or pop? Jacobs T Nat Biotechnol; 2004 Aug; 22(8):949. PubMed ID: 15286641 [No Abstract] [Full Text] [Related]
11. Increasing number of companies found ineligible for SBIR funding. Bouchie A Nat Biotechnol; 2003 Oct; 21(10):1121-2. PubMed ID: 14520384 [No Abstract] [Full Text] [Related]
12. Looking at US versus European exit opportunities. Lawrence S Nat Biotechnol; 2005 Oct; 23(10):1203. PubMed ID: 16302294 [No Abstract] [Full Text] [Related]
13. Mind the (biomedical funding) gap. Klausner A Nat Biotechnol; 2005 Oct; 23(10):1217-8. PubMed ID: 16211055 [No Abstract] [Full Text] [Related]
16. Trends in biopharmaceutical IPOS: 1996-2005. Williams DR; Young CC J Health Care Finance; 2006; 33(2):39-54. PubMed ID: 19175239 [TBL] [Abstract][Full Text] [Related]
17. VC funding hits high in Q1. Lawrence S Nat Biotechnol; 2007 May; 25(5):496. PubMed ID: 17483825 [No Abstract] [Full Text] [Related]
18. The stampede to convertibles. Jacobs T Nat Biotechnol; 2003 Aug; 21(8):855. PubMed ID: 12894195 [No Abstract] [Full Text] [Related]
19. Venture capital for the pharmacologist. Miller LG Mol Interv; 2001 Dec; 1(5):242-4. PubMed ID: 14993362 [No Abstract] [Full Text] [Related]
20. When your stock takes a nosedive. Jacobs T Nat Biotechnol; 2006 Feb; 24(2):144. PubMed ID: 16465152 [No Abstract] [Full Text] [Related] [Next] [New Search]